Similar articles for PMID: 33348852

Year	Number of Results
1991	1
1999	1
2000	2
2001	1
2002	2
2003	2
2005	4
2006	2
2007	1
2008	1
2010	1
2011	4
2012	2
2013	3
2014	2
2015	6
2016	8
2017	11
2018	9
2019	13
2020	6
2021	3
2022	2
2023	0

1

PC945, a Novel Inhaled Antifungal Agent, for the Treatment of Respiratory Fungal Infections.

Murray A, Cass L, Ito K, Pagani N, Armstrong-James D, Dalal P, Reed A, Strong P. Murray A, et al. J Fungi (Basel). 2020 Dec 17;6(4):373. doi: 10.3390/jof6040373. J Fungi (Basel). 2020. PMID: 33348852 Free PMC article. Review.

2

In Vitro and In Vivo Antifungal Profile of a Novel and Long-Acting Inhaled Azole, PC945, on Aspergillus fumigatus Infection.

Colley T, Alanio A, Kelly SL, Sehra G, Kizawa Y, Warrilow AGS, Parker JE, Kelly DE, Kimura G, Anderson-Dring L, Nakaoki T, Sunose M, Onions S, Crepin D, Lagasse F, Crittall M, Shannon J, Cooke M, Bretagne S, King-Underwood J, Murray J, Ito K, Strong P, Rapeport G. Colley T, et al. Antimicrob Agents Chemother. 2017 Apr 24;61(5):e02280-16. doi: 10.1128/AAC.02280-16. Print 2017 May. Antimicrob Agents Chemother. 2017. PMID: 28223388 Free PMC article.

3

In Vivo Biomarker Analysis of the Effects of Intranasally Dosed PC945, a Novel Antifungal Triazole, on Aspergillus fumigatus Infection in Immunocompromised Mice.

Kimura G, Nakaoki T, Colley T, Rapeport G, Strong P, Ito K, Kizawa Y. Kimura G, et al. Antimicrob Agents Chemother. 2017 Aug 24;61(9):e00124-17. doi: 10.1128/AAC.00124-17. Print 2017 Sep. Antimicrob Agents Chemother. 2017. PMID: 28630185 Free PMC article.

4

Relationship between anti-fungal effects and lung exposure of PC945, a novel inhaled antifungal agent, in Aspergillus fumigatus infected mice: Pulmonary PK-PD analysis of anti-fungal PC945.

Ito K, Kizawa Y, Kimura G, Nishimoto Y, Daly L, Knowles I, Hows M, Ayrton J, Strong P. Ito K, et al. Eur J Pharm Sci. 2021 Aug 1;163:105878. doi: 10.1016/j.ejps.2021.105878. Epub 2021 May 18. Eur J Pharm Sci. 2021. PMID: 34015430 Free article.

5

Antifungal synergy of a topical triazole, PC945, with a systemic triazole against respiratory Aspergillus fumigatus infection.

Colley T, Sehra G, Daly L, Kimura G, Nakaoki T, Nishimoto Y, Kizawa Y, Strong P, Rapeport G, Ito K. Colley T, et al. Sci Rep. 2019 Jul 1;9(1):9482. doi: 10.1038/s41598-019-45890-w. Sci Rep. 2019. PMID: 31263150 Free PMC article.

6

Safety and nonclinical and clinical pharmacokinetics of PC945, a novel inhaled triazole antifungal agent.

Cass L, Murray A, Davis A, Woodward K, Albayaty M, Ito K, Strong P, Ayrton J, Brindley C, Prosser J, Murray J, French E, Haywood P, Wallis C, Rapeport G. Cass L, et al. Pharmacol Res Perspect. 2021 Feb;9(1):e00690. doi: 10.1002/prp2.690. Pharmacol Res Perspect. 2021. PMID: 33340279 Free PMC article. Clinical Trial.

7

In vitro antifungal activity of a novel topical triazole PC945 against emerging yeast Candida auris.

Rudramurthy SM, Colley T, Abdolrasouli A, Ashman J, Dhaliwal M, Kaur H, Armstrong-James D, Strong P, Rapeport G, Schelenz S, Ito K, Chakrabarti A. Rudramurthy SM, et al. J Antimicrob Chemother. 2019 Oct 1;74(10):2943-2949. doi: 10.1093/jac/dkz280. J Antimicrob Chemother. 2019. PMID: 31325309 Free PMC article.

8

Anti-fungal activity of a novel triazole, PC1244, against emerging azole-resistant Aspergillus fumigatus and other species of Aspergillus.

Colley T, Sharma C, Alanio A, Kimura G, Daly L, Nakaoki T, Nishimoto Y, Bretagne S, Kizawa Y, Strong P, Rapeport G, Ito K, Meis JF, Chowdhary A. Colley T, et al. J Antimicrob Chemother. 2019 Oct 1;74(10):2950-2958. doi: 10.1093/jac/dkz302. J Antimicrob Chemother. 2019. PMID: 31361006 Free PMC article.

9

Inhaled antifungal therapy: benefits, challenges, and clinical applications.

Ito K. Ito K. Expert Opin Drug Deliv. 2022 Jul;19(7):755-769. doi: 10.1080/17425247.2022.2084530. Epub 2022 Jun 2. Expert Opin Drug Deliv. 2022. PMID: 35634895 Review.

10

In vitro and in vivo antifungal activities of FX0685, a novel triazole antifungal agent with potent activity against fluconazole-resistant Candida albicans.

Takahata S, Okutomi T, Ohtsuka K, Hoshiko S, Uchida K, Yamaguchi H. Takahata S, et al. Med Mycol. 2005 May;43(3):227-33. doi: 10.1080/13693780410001731600. Med Mycol. 2005. PMID: 16010849

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed